Company · CIK 0001651308 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BeOne Medicines Ltd. · ONC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 31,027 | $36.90 | $1,144,896 | 31,027 | — | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 38,287 | $349.10 | $13,366,092 | 0 | −100% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 5:17 pm EDT | Titus B. BallPrincipal Accounting Officer | 132 | $355.86 | $46,974 | 0 | −100% | |
| Aug 25, 2026 SForm 4 → | Aug 27, 5:12 pm EDT | Xiaobin WuPresident and COO | 280 | $380.00 | $106,400 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 2,666 | $360.00 | $959,760 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 2,666 | $191.37 | $510,190 | 2,666 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 12, 5:53 pm EDT | John OylerChief Executive Officer, Director | 240,810 | $359.12 | $86,480,472 | 0 | −100% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 5:15 pm EDT | Aaron RosenbergChief Financial Officer | 1,157 | $312.72 | $361,811 | 0 | −100% | |
| Jul 30, 2026 SForm 4 → | Aug 3, 5:18 pm EDT | Chan Henry LeeSVP, General Counsel | 1,044 | $323.69 | $337,932 | 0 | −100% | |
| Jul 22, 2026 SForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 1,669 | $325.00 | $542,425 | 0 | −100% | 10b5-1 |
| Jul 22, 2026 MForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 1,669 | $191.58 | $319,740 | 1,669 | — | 10b5-1 |
| Jul 20, 2026 MForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 33,990 | $119.96 | $4,077,440 | 33,990 | — | 10b5-1 |
| Jul 20, 2026 SForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 109,713 | $315.28 | $34,590,855 | 0 | −100% | 10b5-1 |
| Jul 17, 2026 SForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 64,628 | $312.00 | $20,163,907 | 0 | −100% | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 64,628 | $119.96 | $7,752,775 | 64,628 | — | 10b5-1 |
| Jul 15, 2026 SForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 283,154 | $315.56 | $89,351,598 | 0 | −100% | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 283,154 | $145.28 | $41,137,996 | 166,597 | — | 10b5-1 |
| Jul 14, 2026 MForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 133,600 | $54.06 | $7,222,959 | 133,600 | — | 10b5-1 |
| Jul 14, 2026 SForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 145,861 | $305.95 | $44,626,424 | 0 | −100% | 10b5-1 |
| Jul 10, 2026 SForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 60,218 | $303.18 | $18,256,808 | 0 | −100% | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 60,218 | $36.90 | $2,222,044 | 48,520 | — | 10b5-1 |
| Jul 8, 2026 SForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 664 | $302.46 | $200,833 | 0 | −100% | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 664 | $191.56 | $127,196 | 664 | — | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 25, 5:15 pm EDT | Xiaobin WuPresident and COO | 1,292 | $276.26 | $356,927 | 0 | −100% | |
| Jun 23, 2026 SForm 4 → | Jun 25, 5:15 pm EDT | John OylerChief Executive Officer, Director | 3,410 | $273.78 | $933,592 | 0 | −100% | |
| Jun 23, 2026 SForm 4 → | Jun 25, 5:14 pm EDT | Lai WangPresident, Global Head of R&D | 1,068 | $276.74 | $295,553 | 0 | −100% | |
| Jun 16, 2026 SForm 4 → | Jun 18, 5:19 pm EDT | Xiaobin WuPresident and COO | 1,357 | $266.76 | $361,997 | 0 | −100% | |
| Jun 16, 2026 SForm 4 → | Jun 18, 5:19 pm EDT | John OylerChief Executive Officer, Director | 3,693 | $265.55 | $980,686 | 0 | −100% | |
| Jun 16, 2026 SForm 4 → | Jun 18, 5:19 pm EDT | Chan Henry LeeSVP, General Counsel | 590 | $265.98 | $156,925 | 0 | −100% | |
| Jun 16, 2026 SForm 4 → | Jun 18, 5:19 pm EDT | Lai WangPresident, Global Head of R&D | 1,169 | $265.39 | $310,236 | 0 | −100% | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | Titus B. BallPrincipal Accounting Officer | 169 | $257.20 | $43,467 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Titus B. BallPrincipal Accounting Officer | 31,213 | — | — | 99,645 | — | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | Lai WangPresident, Global Head of R&D | 756 | $261.00 | $197,318 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Lai WangPresident, Global Head of R&D | 118,625 | — | — | 1,710,085 | — | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | Aaron RosenbergChief Financial Officer | 631 | $257.74 | $162,637 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Aaron RosenbergChief Financial Officer | 71,175 | — | — | 397,891 | — | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | Xiaobin WuPresident and COO | 626 | $261.20 | $163,512 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Xiaobin WuPresident and COO | 118,625 | — | — | 1,308,161 | — | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | Chan Henry LeeSVP, General Counsel | 428 | $257.64 | $110,268 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Chan Henry LeeSVP, General Counsel | 45,071 | — | — | 346,554 | — | |
| Jun 11, 2026 SForm 4 → | Jun 15, 5:55 pm EDT | John OylerChief Executive Officer, Director | 1,949 | $257.24 | $501,355 | 0 | −100% | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | John OylerChief Executive Officer, Director | 177,931 | — | — | 5,697,649 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:54 pm EDT | Xiaodong WangDirector | 99,892 | — | — | 4,682,493 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:51 pm EDT | Olivier BrandicourtDirector | 18,980 | — | — | 46,306 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:50 pm EDT | Anthony C HooperDirector | 18,980 | — | — | 83,720 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:50 pm EDT | Elizabeth Fisher MooneyDirector | 18,980 | — | — | 18,980 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:50 pm EDT | Margaret DuganDirector | 18,980 | — | — | 73,164 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:49 pm EDT | Charles Lazelle SawyersDirector | 18,980 | — | — | 18,984 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:49 pm EDT | Shalini SharpDirector | 18,980 | — | — | 38,116 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:49 pm EDT | Alessandro RivaDirector | 18,980 | — | — | 73,164 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 4:38 pm EDT | BAKER BROS. ADVISORS LP +5Director | 37,960 | — | — | 161,550 | — | |
| Jun 8, 2026 SForm 4 → | Jun 10, 5:27 pm EDT | Titus B. BallPrincipal Accounting Officer | 136 | $271.33 | $36,901 | 0 | −100% | |
| Jun 8, 2026 SForm 4 → | Jun 10, 5:26 pm EDT | Chan Henry LeeSVP, General Counsel | 871 | $270.42 | $235,539 | 0 | −100% | |
| Jun 8, 2026 SForm 4 → | Jun 10, 5:25 pm EDT | Lai WangPresident, Global Head of R&D | 1,367 | $269.38 | $368,247 | 0 | −100% | |
| Jun 8, 2026 SForm 4 → | Jun 10, 5:23 pm EDT | Xiaobin WuPresident and COO | 1,484 | $269.37 | $399,738 | 0 | −100% | |
| Jun 8, 2026 SForm 4 → | Jun 10, 5:22 pm EDT | John OylerChief Executive Officer, Director | 4,940 | $270.56 | $1,336,548 | 0 | −100% | |
| Jun 1, 2026 SForm 4 → | Jun 3, 4:10 pm EDT | Qingqing YiDirector | 235 | $279.13 | $65,596 | 0 | −100% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 4:49 pm EDT | Xiaodong WangDirector | 403,351 | — | — | 1,210,079 | — | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 8:54 pm EDT | Chan Henry LeeSVP, General Counsel | 34,658 | — | — | 88,582 | — | 10b5-1 |
| Jul 22, 2026 MForm 4 → | Jul 24, 4:51 pm EDT | Chan Henry LeeSVP, General Counsel | 21,697 | — | — | 98,930 | — | 10b5-1 |
| Jul 20, 2026 MForm 4 → | Jul 22, 5:03 pm EDT | John OylerChief Executive Officer, Director | 441,870 | — | — | 0 | — | 10b5-1 |
| Jul 17, 2026 MForm 4 → | Jul 17, 5:36 pm EDT | John OylerChief Executive Officer, Director | 840,164 | — | — | 441,870 | — | 10b5-1 |
| Jul 15, 2026 MForm 4 → | Jul 17, 5:31 pm EDT | John OylerChief Executive Officer, Director | 3,681,002 | — | — | 1,282,034 | — | 10b5-1 |
| Jul 14, 2026 MForm 4 → | Jul 14, 9:26 pm EDT | John OylerChief Executive Officer, Director | 1,736,800 | — | — | 462,866 | — | 10b5-1 |
| Jul 10, 2026 MForm 4 → | Jul 14, 9:25 pm EDT | John OylerChief Executive Officer, Director | 782,834 | — | — | 1,264,666 | — | 10b5-1 |
| Jul 8, 2026 MForm 4 → | Jul 10, 4:44 pm EDT | Chan Henry LeeSVP, General Counsel | 8,632 | — | — | 105,300 | — | 10b5-1 |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Lai WangPresident, Global Head of R&D | 229,775 | — | — | 229,775 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Aaron RosenbergChief Financial Officer | 137,865 | — | — | 137,865 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Xiaobin WuPresident and COO | 229,775 | — | — | 229,775 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | Chan Henry LeeSVP, General Counsel | 87,308 | — | — | 87,308 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:55 pm EDT | John OylerChief Executive Officer, Director | 344,669 | — | — | 344,669 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:54 pm EDT | Xiaodong WangDirector | 193,492 | — | — | 193,492 | — |